SCHEMBL9114091

SCHEMBL9114091

[CH2]C=CCc1coc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.46
▸ CA2 P00918 1/20 0.44
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C8 P10632 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2B6 P20813 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ CYP17A1 P05093 1/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ PTPN1 P18031 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ IL4I1 Q96RQ9 1/20 0.38
▸ PSMB8 P28062 1/20 0.38
▸ PSMB5 P28074 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13134181 0.81 MAOB (0.49) MAOBCA2CYP1A2CYP3A4CYP2C8
SCHEMBL30633849 0.78 MAOB (0.53) MAOBCA2CYP17A1CYP19A1CYP11B1
SCHEMBL1299218 0.78 MAOB (0.53) MAOBCA2CYP17A1CYP19A1CYP11B1
SCHEMBL2092249 0.75 MAOB (0.53) MAOBCA2CYP17A1CYP19A1CYP11B1
SCHEMBL6511946 0.72 MAOB (0.71) MAOBCA2CYP17A1CYP19A1CYP11B1
SCHEMBL30396397 0.72 HTR1D (0.53) MAOBCA2CYP1A2CYP3A4CYP2D6
SCHEMBL7360353 0.72 MAOB (0.50) MAOBCA2CYP17A1CYP19A1CYP11B1
SCHEMBL140189 0.72 HTR1D (0.53) MAOBCA2CYP1A2CYP3A4CYP2D6
SCHEMBL19110102 0.71 MAOB (0.46) MAOBCA2CYP1A2CYP3A4CYP2C8
SCHEMBL15075824 0.71 MAOB (0.53) MAOBCA2CYP17A1CYP19A1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 — — EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 — — WO disclosed
Send feedback